Elevance Health, Inc. ELV
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $199.1B | +12% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Operating income | $7.2B | -8% | FY ending Dec 31, 2025 |
| Net income | $5.7B | -5% | FY ending Dec 31, 2025 |
| Earnings per share | $25.21 | -2% | FY ending Dec 31, 2025 |
| Cash from operations | $4.3B | -26% | FY ending Dec 31, 2025 |
| Capital spending | $1.1B | -11% | FY ending Dec 31, 2025 |
| Share buybacks | $2.6B | -10% | FY ending Dec 31, 2025 |
| Dividends paid | $1.5B | +1% | FY ending Dec 31, 2025 |
| Cash | $9.5B | +15% | FY ending Dec 31, 2025 |
| Long-term debt | $30.8B | +5% | FY ending Dec 31, 2025 |
| Shareholders' equity | $43.9B | +6% | FY ending Dec 31, 2025 |
| Shares outstanding | 221M | -3% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 3 open-market buys ($2.2M) and 6 sales ($6.4M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mark KayeEVP & CFO | Sold13 fills | 10,584 | $440.13 avg | $4.7M | Oct 22, 2026 |
| Gail BoudreauxPresident and CEO, Director | Bought2 fills | 2,725 | $367.79 avg | $1.0M | Jul 17, 2026 |
| Ramiro G PeruDirector | Bought | 1,000 | $366.05 | $366K | Jul 17, 2026 |
| Ronald W PenczekCAO & Controller | Sold | 369 | $403.16 | $149K | Jun 12, 2026 |
| Robert L Jr DixonDirector | Sold | 151 | $401.77 | $61K | Jun 11, 2026 |
| Ronald W PenczekCAO & Controller | Sold | 1,531 | $403.13 | $617K | May 19, 2026 |
| Amy W SchulmanDirector | Sold | 26 | $287.50 | $7,475 | Mar 12, 2026 |
| Charles Morgan Jr KendrickEVP & President, Commercial | Sold | 3,196 | $284.92 | $911K | Mar 6, 2026 |
| Steven H CollisDirector | Bought | 3,000 | $289.84 | $870K | Mar 5, 2026 |
Other insider moves (44): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mark KayeEVP & CFO | Tax withholding | 4,161 | $386.43 | $1.6M | Oct 2, 2026 |
| Mark KayeEVP & CFO | Award | 2,627 | – | – | Oct 2, 2026 |
| Erin M WesslingEVP & Chief Legal Officer | Tax withholding | 255 | $414.78 | $106K | Sep 3, 2026 |
| Ryan R CraigEVP & Chief HR Officer | Tax withholding | 144 | $405.84 | $58K | Sep 2, 2026 |
| Erin M WesslingEVP & Chief Legal Officer | Tax withholding | 94 | $405.84 | $38K | Sep 2, 2026 |
| Ronald W PenczekCAO & Controller | Option exercise2 fills | 1,531 | $294.30 avg | $451K | May 19, 2026 |
| Deanna D Strable-SoethoutDirector | Award | 563 | – | – | May 13, 2026 |
| Amy W SchulmanDirector | Award | 563 | – | – | May 13, 2026 |
| Ryan M. SchneiderDirector | Award | 563 | – | – | May 13, 2026 |
| Ramiro G PeruDirector | Award | 563 | – | – | May 13, 2026 |
| Antonio F NeriDirector | Award | 563 | – | – | May 13, 2026 |
| Bahija JallalDirector | Award | 563 | – | – | May 13, 2026 |
| Lewis Iii HayDirector | Award | 563 | – | – | May 13, 2026 |
| Robert L Jr DixonDirector | Award | 563 | – | – | May 13, 2026 |
| Susan D. DevoreDirector | Award | 563 | – | – | May 13, 2026 |
| Steven H CollisDirector | Award | 563 | – | – | May 13, 2026 |
| Gail BoudreauxPresident and CEO, Director | Tax withholding | 1,736 | $284.03 | $493K | Mar 3, 2026 |
| Felicia F NorwoodEVP &Chief Health Benefits Ofr | Tax withholding | 496 | $284.03 | $141K | Mar 3, 2026 |
| Charles Morgan Jr KendrickEVP & President, Commercial | Tax withholding | 467 | $284.03 | $133K | Mar 3, 2026 |
| Peter D HaytaianEVP & Pres Carelon & CarelonRx | Tax withholding | 446 | $284.03 | $127K | Mar 3, 2026 |
| Erin M WesslingEVP & Chief Legal Officer | Tax withholding | 417 | $284.03 | $118K | Mar 3, 2026 |
| Mark KayeEVP & CFO | Tax withholding | 353 | $284.03 | $100K | Mar 3, 2026 |
| Ryan R CraigEVP & Chief HR Officer | Tax withholding | 309 | $284.03 | $88K | Mar 3, 2026 |
| Ratnakar LavuEVP & Chief Digital Info Ofr | Tax withholding | 222 | $284.03 | $63K | Mar 3, 2026 |
| Ronald W PenczekCAO & Controller | Tax withholding | 37 | $284.03 | $11K | Mar 3, 2026 |
| Gail BoudreauxPresident and CEO, Director | Tax withholding | 6,713 | $294.07 | $2.0M | Mar 2, 2026 |
| Felicia F NorwoodEVP &Chief Health Benefits Ofr | Tax withholding | 1,421 | $294.07 | $418K | Mar 2, 2026 |
| Charles Morgan Jr KendrickEVP & President, Commercial | Tax withholding | 1,211 | $294.07 | $356K | Mar 2, 2026 |
| Peter D HaytaianEVP & Pres Carelon & CarelonRx | Tax withholding | 1,201 | $294.07 | $353K | Mar 2, 2026 |
| Ratnakar LavuEVP & Chief Digital Info Ofr | Tax withholding | 315 | $294.07 | $93K | Mar 2, 2026 |
| Mark KayeEVP & CFO | Tax withholding | 271 | $294.07 | $80K | Mar 2, 2026 |
| Ronald W PenczekCAO & Controller | Tax withholding | 131 | $294.07 | $39K | Mar 2, 2026 |
| Ryan R CraigEVP & Chief HR Officer | Tax withholding | 25 | $294.07 | $7,352 | Mar 2, 2026 |
| Ronald W PenczekCAO & Controller | Award3 fills | 2,393 | – | – | Mar 2, 2026 |
| Erin M WesslingEVP & Chief Legal Officer | Award | 2,976 | – | – | Mar 2, 2026 |
| Ryan R CraigEVP & Chief HR Officer | Award | 2,976 | – | – | Mar 2, 2026 |
| Felicia F NorwoodEVP &Chief Health Benefits Ofr | Award2 fills | 8,816 | – | – | Mar 2, 2026 |
| Ratnakar LavuEVP & Chief Digital Info Ofr | Award2 fills | 11,903 | – | – | Mar 2, 2026 |
| Charles Morgan Jr KendrickEVP & President, Commercial | Award2 fills | 6,549 | – | – | Mar 2, 2026 |
| Peter D HaytaianEVP & Pres Carelon & CarelonRx | Award | 2,865 | – | – | Mar 2, 2026 |
| Mark KayeEVP & CFO | Award2 fills | 16,579 | – | – | Mar 2, 2026 |
| Gail BoudreauxPresident and CEO, Director | Award2 fills | 26,680 | – | – | Mar 2, 2026 |
| Ryan R CraigEVP & Chief HR Officer | Tax withholding | 279 | $341.83 | $95K | Feb 2, 2026 |
| Amy W SchulmanDirector | Award | 218 | – | – | Feb 2, 2026 |
Trades by members of Congress
7 members reported 6 buys and 10 sales since Oct 29, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Lisa C. McClain R | Sold | $1,001–$15K | Aug 13, 2025 | Sep 12, 2025 | Spouse |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Aug 5, 2025 | Sep 12, 2025 | Self |
| Val T. Hoyle D | Sold | $1,001–$15K | Jan 13, 2025 | Sep 12, 2025242 days later | Spouse |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jul 10, 2025 | Aug 13, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jun 24, 2025 | Aug 13, 202550 days later | Spouse |
| Jefferson Shreve R | Sold | $15K–$50K | May 12, 2025 | Jun 22, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold | $1,001–$15K | May 30, 2025 | Jun 6, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Sold | $15K–$50K | May 15, 2025 | May 31, 2025 | Self |
| Dan Newhouse R | Sold some | $1,001–$15K | Apr 11, 2025 | May 16, 2025 | Spouse |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Apr 29, 2025 | May 6, 2025 | Self |
| Jared Moskowitz D | Sold | $1,001–$15K | Mar 10, 2025 | Apr 8, 2025 | Child |
| Jared Moskowitz D | Sold | $1,001–$15K | Mar 10, 2025 | Apr 8, 2025 | Child |
| Jared Moskowitz D | Sold | $1,001–$15K | Mar 10, 2025 | Apr 8, 2025 | Self |
| Jefferson Shreve R | Bought | $15K–$50K | Feb 24, 2025 | Mar 9, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | Jan 13, 2025 | Feb 13, 2025 | Joint |
Latest SEC filings
- Insider plans to sell 144 · Oct 22, 2026
- Quarterly report 10-Q · Oct 21, 2026
- News filing: Quarterly results 8-K · Oct 21, 2026
- News filing: Public announcement (Reg FD) 8-K · Sep 10, 2026
- Quarterly report 10-Q · Jul 15, 2026
- News filing: Quarterly results 8-K · Jul 15, 2026
- Insider plans to sell 144 · Jul 7, 2026
- Insider plans to sell 144 · Jun 12, 2026
- Insider plans to sell 144 · Jun 11, 2026
- News filing: Public announcement (Reg FD) 8-K · Jun 10, 2026
- Insider plans to sell 144 · May 19, 2026
- News filing: Shareholder vote results 8-K · May 13, 2026
- Quarterly report 10-Q · Apr 22, 2026
- News filing: Quarterly results 8-K · Apr 22, 2026
- Shareholder meeting proxy DEF 14A · Mar 27, 2026
- News filing: Public announcement (Reg FD) 8-K · Mar 10, 2026
- Insider plans to sell 144 · Mar 6, 2026
- News filing: Other news 8-K · Mar 2, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Feb 26, 2026
- Annual report 10-K · Feb 6, 2026
- News filing: Quarterly results 8-K · Jan 28, 2026
- News filing: Executive or board change 8-K · Dec 10, 2025
- News filing: Public announcement (Reg FD) 8-K · Nov 10, 2025
- Quarterly report 10-Q · Oct 21, 2025
- News filing: Quarterly results 8-K · Oct 21, 2025
About Elevance Health, Inc.
Business description
- Industry
- Hospital & Medical Service Plans
- Sector
- Finance
- Headquarters
- Indianapolis, IN
- Incorporated in
- IN
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- SEC company number (CIK)
- 1156039
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.